ZLAB - Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs
- Zai Lab raised a staggering $750 million in a private placement of its dual US/Hong Kong-listed stock.
- Shanghai Junshi Bio completed its $50 million investment into its US partner, Coherus BioSciences.
- Tianjin CanSino Biologics will start a clinical trial of an inhaled COVID-19 vaccine in China.
For further details see:
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs